Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

An RNA-Binding Protein Secreted by a Bacterial Pathogen Modulates RIG-I Signaling.

Pagliuso A, Tham TN, Allemand E, Robertin S, Dupuy B, Bertrand Q, Bécavin C, Koutero M, Najburg V, Nahori MA, Tangy F, Stavru F, Bessonov S, Dessen A, Muchardt C, Lebreton A, Komarova AV, Cossart P.

Cell Host Microbe. 2019 Nov 4. pii: S1931-3128(19)30528-1. doi: 10.1016/j.chom.2019.10.004. [Epub ahead of print]

2.

LGP2 binds to PACT to regulate RIG-I- and MDA5-mediated antiviral responses.

Sanchez David RY, Combredet C, Najburg V, Millot GA, Beauclair G, Schwikowski B, Léger T, Camadro JM, Jacob Y, Bellalou J, Jouvenet N, Tangy F, Komarova AV.

Sci Signal. 2019 Oct 1;12(601). pii: eaar3993. doi: 10.1126/scisignal.aar3993.

PMID:
31575732
3.

Strong antigen-specific T-cell immunity induced by a recombinant human TERT measles virus vaccine and amplified by a DNA/viral vector prime boost in IFNAR/CD46 mice.

Pliquet E, Ruffie C, Escande M, Thalmensi J, Najburg V, Combredet C, Bestetti T, Julithe M, Liard C, Huet T, Wain-Hobson S, Tangy F, Langlade-Demoyen P.

Cancer Immunol Immunother. 2019 Apr;68(4):533-544. doi: 10.1007/s00262-018-2272-3. Epub 2019 Jan 17.

PMID:
30656384
4.

RIG-I Recognizes the 5' Region of Dengue and Zika Virus Genomes.

Chazal M, Beauclair G, Gracias S, Najburg V, Simon-Lorière E, Tangy F, Komarova AV, Jouvenet N.

Cell Rep. 2018 Jul 10;24(2):320-328. doi: 10.1016/j.celrep.2018.06.047.

5.

Nonencapsidated 5' Copy-Back Defective Interfering Genomes Produced by Recombinant Measles Viruses Are Recognized by RIG-I and LGP2 but Not MDA5.

Mura M, Combredet C, Najburg V, Sanchez David RY, Tangy F, Komarova AV.

J Virol. 2017 Sep 27;91(20). pii: e00643-17. doi: 10.1128/JVI.00643-17. Print 2017 Oct 15.

6.

Large-scale nucleotide optimization of simian immunodeficiency virus reduces its capacity to stimulate type I interferon in vitro.

Vabret N, Bailly-Bechet M, Lepelley A, Najburg V, Schwartz O, Verrier B, Tangy F.

J Virol. 2014 Apr;88(8):4161-72. doi: 10.1128/JVI.03223-13. Epub 2014 Jan 29.

7.

A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus.

Brandler S, Ruffié C, Combredet C, Brault JB, Najburg V, Prevost MC, Habel A, Tauber E, Desprès P, Tangy F.

Vaccine. 2013 Aug 12;31(36):3718-25. doi: 10.1016/j.vaccine.2013.05.086. Epub 2013 Jun 4.

PMID:
23742993
8.

The biased nucleotide composition of HIV-1 triggers type I interferon response and correlates with subtype D increased pathogenicity.

Vabret N, Bailly-Bechet M, Najburg V, Müller-Trutwin M, Verrier B, Tangy F.

PLoS One. 2012;7(4):e33502. doi: 10.1371/journal.pone.0033502. Epub 2012 Apr 18.

9.

A chimeric measles virus with a lentiviral envelope replicates exclusively in CD4+/CCR5+ cells.

Mourez T, Mesel-Lemoine M, Combredet C, Najburg V, Cayet N, Tangy F.

Virology. 2011 Oct 25;419(2):117-25. doi: 10.1016/j.virol.2011.08.007. Epub 2011 Sep 3.

10.

Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses.

Brandler S, Ruffie C, Najburg V, Frenkiel MP, Bedouelle H, Desprès P, Tangy F.

Vaccine. 2010 Sep 24;28(41):6730-9. doi: 10.1016/j.vaccine.2010.07.073. Epub 2010 Aug 3.

PMID:
20688034
11.

Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160DeltaV1V2 is strongly immunogenic.

Guerbois M, Moris A, Combredet C, Najburg V, Ruffié C, Février M, Cayet N, Brandler S, Schwartz O, Tangy F.

Virology. 2009 May 25;388(1):191-203. doi: 10.1016/j.virol.2009.02.047. Epub 2009 Apr 5.

Supplemental Content

Loading ...
Support Center